Nervous system lyme disease: Diagnosis and treatment

Reviews in Neurological Diseases

Volumn 6, Issue 1, 2009, Pages 4-12

  Halperin, John J ^a  

^a Atlantic Neuroscience Institute   (United States)

Author keywords

Borrelia burgdorferi; Erythema migrans; Lyme disease; Nervous system; Neuroborreliosis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; DOXYCYCLINE; ERYTHROMYCIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENICILLIN G; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTHRITIS; ASEPTIC MENINGITIS; B LYMPHOCYTE; BACTERIAL MENINGITIS; BORRELIA BURGDORFERI; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; DERMATOME; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG PENETRATION; DRUG POTENCY; DRUG TREATMENT FAILURE; ENCEPHALITIS; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; EUROPE; FEVER; HEADACHE; HEART DISEASE; HUMAN; IMMUNOGLOBULIN PRODUCING CELL; LABORATORY DIAGNOSIS; LYME DISEASE; LYMPHOCYTE MIGRATION; MENINGITIS; MULTIPLE SCLEROSIS; NEURITIS; NEUROBORRELIOSIS; NEUROTRANSMISSION; NORTH AMERICA; PERIPHERAL NERVOUS SYSTEM; PHOTOSENSITIVITY; POLYMERASE CHAIN REACTION; PROTEIN CEREBROSPINAL FLUID LEVEL; RADICULAR PAIN; RADICULITIS; RASH; REVIEW; RURAL AREA; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR NEUROPATHY; SERODIAGNOSIS; SUBURBAN AREA; TICK BITE; TREATMENT DURATION; WESTERN BLOTTING;

BACTERIAL PROTEINS; BORRELIA BURGDORFERI; HISTORY, 20TH CENTURY; HUMANS; LYME NEUROBORRELIOSIS;

EID: 63849088719     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Steere AC, Malawista SE, Hardin JA, et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977;86:685-698.
2. Afzelius A. Verhandlugen der dermatorischen Gesellshaft zu Stockholm. Arch Derm Syphiligr. 1910;101:404.
3. Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon. 1922;71:765-767.
4. Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und "rheumatismus." Arch Psychiatr Nervenkr. 1941; 113:284-376.
5. Hellerstrom S. Erythema chronicum migrans Afzelius with meningitis. Acta Derm Venereal. 1951;31:227-234.
6. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease-a tick-borne spirochetosis? Science. 1982;216:1317-1319.
7. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. AT Engl 1 Med. 1983;308:733-740.
8. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl / Med. 1983;308: 740-742.
9. Asbrink E, Hederstedt B, Hovmark A. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol. 1984;64:506-512.
10. Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298:279-290.
11. Wharton M, Chorba TL, Vogt RI et al. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep. 1990;39(RR-13):l-43.
12. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med. 1996;335:1270-1274.
13. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med. 2003;348:2472-2474.
14. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992;267:1364-1367.
15. Wormser CP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-1134.
16. Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease-United States, 1992-1998. MMWR CDC Surveill Summ. 2000;49:1-11.
17. Centers for Disease Control and Prevention (CDC). Lyme disease-United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51:29-31.
18. Dattwyler RJ, Volkman DJ, Luft BJ, et al. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med. 1988;319:1441-1446.
19. Dressier F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392-400.
20. Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995; 44:590-591.
21. Halperin JJ. Facial nerve palsy associated with Lyme disease. Muscle Nerve. 2003;28:516-517.
22. Wilske B, Schierz G, Preac-Mursic V, et al. intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis. J Infect Dis. 1986;153:304-314.
23. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571-1582.
24. Hansen K, Lebech A-M. Intrathecal synthesis of Borrelia burgdorferi specific immunoglobulin G, A and M in neuroborreliosis-an antibody capture assay. Paper presented at: IV International Conference on Lyme Borreliosis; Stockholm, Sweden; June 18-21, 1990.
25. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323:1438-1444.
26. Hammers Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43: 169-175.
27. Ljostad U, Mygland A. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients. Neurology. 2008; 71:151.
28. Reik L, Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine (Baltimore). 1979;58:281-294.
29. Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med. 1983;99:767-772.
30. Shah SS, Zaoutis TE, Turnquist J, et al. Early differentiation of Lyme from enteroviral meningitis. Pediatr Infect Dis J. 2005;24: 542-545.
31. Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain. 1990;113: 1207-1221.
32. Sibony P, Halperin J, Coyle PK, Patel K. Reactive Lyme serology in patients with optic neuritis. J Neuroophthalmol. 2005;25:71-82.
33. Roberts ED, Bohm RP Jr, Lowrie RC Jr, et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis. 1998;178: 722-732.
34. England JD, Bohm RP, Roberts ED, Philipp MT. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol. 1997; 41:375-384.
35. Sigal LH, Williams S, Soltys B, Gupta R. H9724, a monoclonal antibody to Borrelia burgdorferi's flagellin, binds to heat shock protein 60 (HSP60) within live neuroblastoma cells: a potential role for HSP60 in peptide hormone signaling and in an autoimmune pathogenesis of the neuropathy of Lyme disease. Cell Mol Neurobial. 2001;21:477-495.
36. Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology. 1990;40:1340-1343.
37. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurology. 1992;42:43-50.
38. Miklossy J, Kasas S, Zurn AD, et al. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Nenroinflammation. 2008;5:40.
39. Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology. 2007;69:91-102.
40. Ljostad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7:690-695.
41. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85-92.
42. Krupp LB, Hyman LG, Crimson R, et al. Study and treatment of post Lyme disease (STOP-l.D): a randomized double masked clinical trial. Neurology. 2003;60:1923-1930.
43. Oksi J, Nikoskelainen J, Hiekkanen H, et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis. 2007;26:571-581.
44. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992-1003.
45. Rothstein JD, Patel S, Regan MR, et al. Beta- lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73-77.
46. Halperin JJ. Prolonged Lyme disease treatment. Neurology. 2008;70:986-987.